Bio-Rad Laboratories
(NYSE) BIO
Bio-Rad Laboratories Financials at a Glance
Market Cap
$7.46B
Revenue (TTM)
$2.58B
Net Income (TTM)
$759.90M
EPS (TTM)
$27.92
P/E Ratio
9.91
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Price
$276.65
Volume
436,678.155
Open
$272.48
Price
$276.65
Volume
436,678.155
Open
$272.48
Previous Close
$276.53
Daily Range
$272.48 - $277.82
52-Week Range
$211.43 - $343.12
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Price
$276.65
Volume
436,678.155
Open
$272.48
Previous Close
$276.53
Daily Range
$272.48 - $277.82
52-Week Range
$211.43 - $343.12
BIO News
BIO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bio-Rad Laboratories
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
7,400
CEO
Norman D. Schwartz
Website
www.bio-rad.comHeadquarters
Hercules, CA 94547, US
BIO Financials
Key Financial Metrics (TTM)
Gross Margin
52%
Operating Margin
9%
Net Income Margin
29%
Return on Equity
11%
Return on Capital
2%
Return on Assets
7%
Earnings Yield
10.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.46B
Shares Outstanding
26.99M
Volume
436.68K
Short Interest
0.00%
Avg. Volume
278.07K
Financials (TTM)
Gross Profit
$1.34B
Operating Income
$270.50M
EBITDA
$475.90M
Operating Cash Flow
$532.20M
Capital Expenditure
$157.60M
Free Cash Flow
$374.60M
Cash & ST Invst.
$1.54B
Total Debt
$1.53B
Bio-Rad Laboratories Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$693.20M
+3.9%
Gross Profit
$345.20M
+1.0%
Gross Margin
49.80%
N/A
Market Cap
$7.46B
N/A
Market Cap/Employee
$969.31K
N/A
Employees
7,700
N/A
Net Income
$720.00M
+200.6%
EBITDA
$114.30M
+113.5%
Quarterly Fundamentals
Net Cash
$11.70M
-96.0%
Accounts Receivable
$472.50M
+4.4%
Inventory
$740.70M
-2.5%
Long Term Debt
$1.49B
+12.1%
Short Term Debt
$37.90M
-11.7%
Return on Assets
7.18%
N/A
Return on Invested Capital
2.28%
N/A
Free Cash Flow
$119.10M
+46.6%
Operating Cash Flow
$164.90M
+32.8%